Emerald Health Therapeutics (CVE:EMH) Stock Price Down 3.8% – Here’s What Happened

Shares of Emerald Health Therapeutics, Inc. (CVE:EMH) traded down 3.8% during mid-day trading on Wednesday . The company traded as low as C$0.25 and last traded at C$0.26. 384,329 shares changed hands during trading, a decline of 40% from the average session volume of 644,760 shares. The stock had previously closed at C$0.27.

Emerald Health Therapeutics Stock Down 3.8 %

The company has a market cap of C$52.28 million and a PE ratio of -0.37. The business has a 50-day simple moving average of C$0.26 and a 200-day simple moving average of C$0.26. The company has a quick ratio of 2.61, a current ratio of 2.97 and a debt-to-equity ratio of 35.45.

Emerald Health Therapeutics Company Profile

Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.